Continue to take atomoxetine even if you feel well.
Atomoxetine administration with substrates of CYP2D6 and CYP3A does not result in clinically significant drug interactions.
For atomoxetine clinical data on exposed pregnancies are limited.
Average risk of suicidal ideation in patients receiving atomoxetine has been shown to be approximately 0. However, these stimulant medications are limited by dose-related s 6. Atomoxetine appeared less likely than methylphenidate to exacerbate disordered sleep in pediatric patients with ADHD.
Safety and efficacy in children under 6 years have not been established. Michelson et al 8 found that improvements in social and family functioning and self esteem were superior among atomoxetine treated patients compared with those in the placebo group.
Atomoxetine will help to reduce the symptoms of hyperactivity and impulsive behaviour and to increase attention and concentration span. It does not appear to have typical psychostimulant or euphoriant properties.
Thus, atomoxetine is a useful option in the treatment of ADHD in children and adolescents.
Ask your doctor before use if you are taking the following medications:
This can lead to serious medical problems including kidney damage, amputations, and blindness.
Older adults may be at greater risk for side effects such as low blood sugar or lactic acidosis.
This means that it is probably safe for use during pregnancy, although the full risks are not currently known.
However, your feedback is important to us. Patients should be instructed to call their doctor as soon as possible should they notice an increase in aggression or hostility. Second, the ratio of drug responders to placebo responders across the range of outcomes can be determined as the area under the curve.
If you would like more information, talk with your doctor. Subscribe to receive email notifications whenever new articles are published. The affinity of atomoxetine for over 60 other neuronal receptors, transporters and binding sites was investigated.